Position statements

Guidelines on TNF - a Bloackers in Ankylosing Spondylitis

Following the recent publication of the ASAS consensus statement, SARAA wishes to comply with these guidelines in the treatment of ankylosing spondylitis in adults.

The full guidelines and can be viewed on the BSR website: http://www.rheumatology.org.uk. The consensus statement is attached.

Please note that only patients with peripheral arthritis will be required to use sulfasalazine before a TNF-a blocker is considered. SARAA is of the opinion that the use of methotrexate in these cases is not inappropriate.

Reference: Ann Rheum Dis 2006;65:316-320.